SUTRO Trademark
Trademark Overview
On Monday, August 12, 2024, a trademark application was filed for SUTRO with the United States Patent and Trademark Office. The USPTO has given the SUTRO trademark a serial number of 98694731. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Tuesday, June 9, 2026. This trademark is owned by Sutro Biopharma, Inc.. The SUTRO trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical and biological preparations for the immune system targeting immuno-oncology pathways; Pharmaceutical and biological preparations for use in oncology; Pharmaceuticals and biological preparations for prophylactic, diagnostic, and therapeutic use in treating, preventing, and managing cancer; Therapeutic agents for medical use, namely, proteins and derivatives, antibody-drug conjugates, immunostimulatory antibody-drug conjugates, dual conjugates, cytokines, bispecific antibodies, and engineered antibodies for destroying tumor cells and stimulating immune response; Vaccines; Bacterial lysate preparations and bacterial extract preparations, for use in the cell free production of therapeutic proteins and peptides for medical use
Custom manufacturing of pharmaceuticals and therapeutic agents for medical use; Custom manufacturing of bacterial lysate preparations and bacterial extract preparations.
Research and development in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory antibody-drug conjugates, dual conjugates, cytokines, bispecific antibodies, engineered antibodies, oncology, and immunology; Providing medical scientific research information in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory anti-drug conjugates, cytokines, bispecific antibodies, engineered antibodies, oncology, and immunology; Drug discovery, custom design, and development services featuring therapeutic agents for the treatment and prevention of diseases.
General Information
| Serial Number | 98694731 |
| Word Mark | SUTRO |
| Filing Date | Monday, August 12, 2024 |
| Status | 748 - STATEMENT OF USE - TO EXAMINER |
| Status Date | Tuesday, June 9, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 27, 2025 |
Trademark Statements
| Goods and Services | Pharmaceutical and biological preparations for the immune system targeting immuno-oncology pathways; Pharmaceutical and biological preparations for use in oncology; Pharmaceuticals and biological preparations for prophylactic, diagnostic, and therapeutic use in treating, preventing, and managing cancer; Therapeutic agents for medical use, namely, proteins and derivatives, antibody-drug conjugates, immunostimulatory antibody-drug conjugates, dual conjugates, cytokines, bispecific antibodies, and engineered antibodies for destroying tumor cells and stimulating immune response; Vaccines; Bacterial lysate preparations and bacterial extract preparations, for use in the cell free production of therapeutic proteins and peptides for medical use |
| Goods and Services | Custom manufacturing of pharmaceuticals and therapeutic agents for medical use; Custom manufacturing of bacterial lysate preparations and bacterial extract preparations. |
| Goods and Services | Research and development in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory antibody-drug conjugates, dual conjugates, cytokines, bispecific antibodies, engineered antibodies, oncology, and immunology; Providing medical scientific research information in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory anti-drug conjugates, cytokines, bispecific antibodies, engineered antibodies, oncology, and immunology; Drug discovery, custom design, and development services featuring therapeutic agents for the treatment and prevention of diseases. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 12, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | Wednesday, July 5, 2017 |
| First Use In Commerce Date | Wednesday, July 5, 2017 |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 12, 2024 |
| Primary Code | 040 |
| First Use Anywhere Date | Monday, August 11, 2014 |
| First Use In Commerce Date | Monday, August 11, 2014 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 12, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, August 11, 2014 |
| First Use In Commerce Date | Monday, August 11, 2014 |
Trademark Owner History
| Party Name | Sutro Biopharma, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | South San Francisco, CA 94080
US |
| Party Name | Sutro Biopharma, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | South San Francisco, CA 94080
US |
Trademark Events
| Event Date | Event Description |
| Monday, August 12, 2024 | NEW APPLICATION ENTERED |
| Thursday, January 16, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, February 19, 2025 | ASSIGNED TO EXAMINER |
| Thursday, February 20, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, February 20, 2025 | NON-FINAL ACTION E-MAILED |
| Thursday, February 20, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, April 22, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, April 22, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, April 22, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, April 25, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 21, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 27, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 27, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 22, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, January 16, 2026 | SOU TEAS EXTENSION RECEIVED |
| Friday, January 16, 2026 | SOU EXTENSION 1 FILED |
| Friday, January 16, 2026 | SOU EXTENSION 1 GRANTED |
| Saturday, January 17, 2026 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, February 24, 2026 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, February 24, 2026 | SOU EXTENSION 2 FILED |
| Tuesday, February 24, 2026 | SOU EXTENSION 2 GRANTED |
| Tuesday, February 24, 2026 | TEAS STATEMENT OF USE RECEIVED |
| Wednesday, February 25, 2026 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, June 9, 2026 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, February 24, 2026 | USE AMENDMENT FILED |
| Tuesday, June 9, 2026 | STATEMENT OF USE PROCESSING COMPLETE |
